KRISTEN FARTHING: Open Payments
NPI 1609163534 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 83 payments from 18 companies in 2025. Trend: 2023 $1,137 · 2024 $1,427 · 2025 $1,492
Food & beverage: $1,395Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $324 |
| Regeneron Healthcare Solutions, Inc. | 9 | $226 |
| Janssen Biotech, Inc. | 13 | $207 |
| UCB, Inc. | 10 | $179 |
| Novartis Pharmaceuticals Corporation | 6 | $142 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Lilly USA, LLC | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $51 |
| LEO Pharma Inc. | 2 | $42 |
| PFIZER INC. | 1 | $40 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, RINVOQ, LIBTAYO, Sotyktu, NEMLUVIO.
Industry payments across IN — which companies pay providers there.
